.. Des-cosmétiques, 89 a. Eczéma de contact et irritations, p.90

. Merck, The Merck Index -An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck research laboratories, 2006.

C. Gourier-fréry, N. Fréry, C. Berr, and S. Cordier, Aluminium : Quels risques pour la santé? Synthèse des études épidémiologiques, 2003.

E. Canada, Liste des substances d'interêt prioritaire

L. Graff, Recherche et étude de nouveaux chélateurs de l'aluminium et du phosphore utilisables en médecine, Thèse de doctorat spécialité Toxicologie de l'environnement, 1996.

R. Yokel, Aluminum chelation principles and recent advances, Coordination Chemistry Reviews, vol.228, issue.2, pp.97-113, 2002.
DOI : 10.1016/S0010-8545(02)00078-4

A. Autret-leca, L. Bensouda-grimaldi, A. Jonville-béra, and F. Beau-salinas, Pharmacovigilance des??vaccins, Archives de P??diatrie, vol.13, issue.2, pp.175-180, 2006.
DOI : 10.1016/j.arcped.2005.10.020

P. Bégué, M. Girard, H. Bazin, and J. Bach, Les adjuvants vaccinaux : quelle actualité, 2012.

D. Générale-de and L. Santé, Comité Technique des Vaccinations, AFSSAPS, INPES. Guide des vaccinations. INPES Editions, 2012.

J. Pilette, Maladies infectieuses et vaccins, 2011.

B. Soubeyrand, Tol??rance des vaccins : faits et sp??culations, M??decine et Maladies Infectieuses, vol.33, issue.6, pp.287-299, 2003.
DOI : 10.1016/S0399-077X(03)00181-1

J. Manus, ?? propos des adjuvants aluminiques des vaccins: La pharmacovigilance, Revue Francophone des Laboratoires, vol.2012, issue.441, pp.42-97
DOI : 10.1016/S1773-035X(12)71421-1

A. Rimaniol, G. Gras, F. Verdier, and F. Capel, Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type, Vaccine, vol.22, issue.23-24, pp.3127-3162, 2004.
DOI : 10.1016/j.vaccine.2004.01.061

R. Flarend, S. Hem, and J. White, In vivo absorption of aluminium-containing vaccine adjuvants using 26Al, Vaccine, vol.15, issue.12-13, pp.1314-1332, 1997.
DOI : 10.1016/S0264-410X(97)00041-8

L. Tomljenovic and C. Shaw, Les adjuvants aluminiques dans les vaccins : sont-ils sans danger ? Curr, Medl. Chem, vol.18, pp.2630-2667, 2011.

L. Keith, D. Jones, and C. Chou, Aluminum toxicokinetics regarding infant diet and vaccinations, Vaccine, vol.20, pp.13-17, 2002.
DOI : 10.1016/S0264-410X(02)00165-2

F. Authier and R. Gherardi, Myofasciite ?? macrophages : ??tat des connaissances, Revue Neurologique, vol.163, issue.10, pp.985-993, 2007.
DOI : 10.1016/S0035-3787(07)92645-4

R. Cohen and E. Grimpel, R??actions secondaires aux vaccins : distinguer le vrai du faux, Archives de P??diatrie, vol.19, issue.6, pp.182-185, 2012.
DOI : 10.1016/S0929-693X(12)71202-2

C. André, F. Batteux, S. Desplat-jego, and M. Dragon-durey, Mécanismes physiopathologiques de l'auto-immunité, 2011.

J. Classen, Risk of vaccine induced diabetes in children with a family history of type 1 diabetes. Open Ped, Med. J, issue.2, pp.7-10, 2008.

D. Wraith, M. Goldman, and P. Lambert, Vaccination and autoimmune disease: what is the evidence?, The Lancet, vol.362, issue.9396, pp.1659-66, 2003.
DOI : 10.14293/S2199-1006.1.SOR-CHEM.A8GWIE.v1.RKNHQI

L. Barbier-sloma, M. Rosenheim, and M. , Vaccination contre l???h??patite B: actualisation sur la s??curit??, Antibiotiques, vol.8, issue.4, pp.248-254, 2006.
DOI : 10.1016/S1294-5501(06)70825-1

M. Hernan, S. Jick, M. Olek, and H. Jjick, Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study, Neurology, vol.63, issue.5, pp.838-842, 2004.
DOI : 10.1212/01.WNL.0000138433.61870.82

D. Alarcon-segovia, E. Fishbein, and E. Diaz-jouanen, Presence of hepatitis-associated antigen in systemic lupus erythematosus, Clin. Exp. Immunol, vol.12, pp.9-19, 1972.

T. Hanslik, J. Vaillant, L. Audrain, and V. Jubault, Lupus ??ryth??mateux syst??mique et risque de la vaccination contre l???h??patite??B??: du niveau de preuve ?? la prescription, La Revue de M??decine Interne, vol.21, issue.9, pp.785-790, 2000.
DOI : 10.1016/S0248-8663(00)00224-1

M. Geier, D. Geier, and A. Zahalsky, Influenza vaccination and Guillain Barre syndrome???, Clinical Immunology, vol.107, issue.2, pp.116-121, 2003.
DOI : 10.1016/S1521-6616(03)00046-9

N. Souayah, A. Nasar, M. Fareed, K. Suri, and A. Qureshi, Guillain???Barre syndrome after vaccination in United States, Vaccine, vol.25, issue.29, pp.5253-55, 2007.
DOI : 10.1016/j.vaccine.2007.03.053

K. Wucherpfennig, Mechanisms for the induction of autoimmunity by infectious agents, Journal of Clinical Investigation, vol.108, issue.8, pp.1097-1104, 2001.
DOI : 10.1172/JCI200114235

X. Mariette, Auto-immunité et virus. La lettre du rhumatologue, pp.22-25, 1999.

P. Lambert, Vaccination et auto-immunité : quel est le problème ?, Rev. Med. Suisse, vol.567, p.7, 2003.

Y. Shoenfeld and N. Agmon-levin, ???ASIA??? ??? Autoimmune/inflammatory syndrome induced by adjuvants, Journal of Autoimmunity, vol.36, issue.1, pp.4-8, 2011.
DOI : 10.1016/j.jaut.2010.07.003

S. Croce, B. Lhermitte, C. Tomasetto, and O. Guillard, Pseudolymphome sous-cutan?? postvaccinal de survenue tardive, Annales de Pathologie, vol.28, issue.2, pp.146-149, 2008.
DOI : 10.1016/j.annpat.2007.11.004

A. Bordet, P. Michenet, C. Cohen, and F. Arbion, Granulome post-vaccinal lié à l'hydroxyde d'aluminium, Ann. Pathol, vol.21, pp.149-152, 2001.

S. Lafaye, F. Authier, S. Fraitag, and L. Rethers, Granulome vaccinal avec hyperplasie lymphocytaire : 10 cas. Présence d'aluminium dans les biopsies, Ann. Dermatol. Venereol, issue.131, pp.769-772, 2004.
DOI : 10.1016/s0151-9638(04)93758-1

C. Longueville, V. Doffoel-hantz, S. Hantz, and N. Souyri, ??ryth??me noueux induit par le Gardasil??, La Revue de M??decine Interne, vol.33, issue.3, pp.17-18, 2012.
DOI : 10.1016/j.revmed.2011.02.013

A. Forgeron, J. Bonneau, A. Hoppe, and M. Drouet, Hypersensibilité retardée à l'aluminium des vaccins : à propos de trois cas, Rev. Fr. Allergol, vol.50, p.331, 2010.

E. Bergfors, C. Björkelund, and B. Trollfors, Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines, European Journal of Pediatrics, vol.22, issue.11, pp.691-697, 2005.
DOI : 10.1007/s00431-005-1704-1

M. Gold, H. Goodwin, S. Botham, and M. Burgess, Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service, Archives of Disease in Childhood, vol.83, issue.2, pp.128-131, 2000.
DOI : 10.1136/adc.83.2.128

C. Ponvert, Les r??actions d???hypersensibilit?? allergique et non allergique aux vaccins contenant des anatoxines, Revue Fran??aise d'Allergologie, vol.49, issue.5, pp.447-451, 2009.
DOI : 10.1016/j.reval.2009.04.007

C. Ponvert and E. Bloch-morot, Les r??actions d???hypersensibilit?? allergiques et non allergiques aux vaccins, Revue Fran??aise d'Allergologie, vol.53, issue.1, p.9
DOI : 10.1016/j.reval.2012.09.001

G. Invs, Myofasciite à macrophages : Rapport d'investigation exploratoire, 2001.

T. Papo, Myofasciite ?? macrophages : maladie syst??mique ou tatouage post-vaccinal ?, Revue Neurologique, vol.163, issue.10, pp.981-984, 2007.
DOI : 10.1016/S0035-3787(07)92644-2

K. Redhead, G. Quinlan, R. Das, and J. Gutteridge, Aluminium-Adjuvanted Vaccines Transiently Increase Aluminium Levels in Murine Brain Tissue, Pharmacology & Toxicology, vol.2, issue.4, pp.278-280, 1992.
DOI : 10.1248/cpb.31.1415

R. Gherardi and F. Authier, Macrophagic myofasciitis: characterization and pathophysiology, Lupus, vol.67, issue.2, pp.184-189, 2012.
DOI : 10.1002/art.27183

URL : https://hal.archives-ouvertes.fr/inserm-00665883

T. Papo, Myofasciite à macrophages : paradigme de nouvelle maladie ? Rev. Méd, Interne, vol.26, pp.175-178, 2005.
DOI : 10.1016/j.revmed.2004.09.017

D. Long and G. , A positive association found between autism prevalence and childhood vaccination uptake across the US population, J. Toxicol. Environ. Health, vol.74, pp.903-916, 2011.

L. Tomljenovic and C. Shaw, Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?, Journal of Inorganic Biochemistry, vol.105, issue.11, pp.1489-99, 2001.
DOI : 10.1016/j.jinorgbio.2011.08.008

C. Shaw and M. Petrik, Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration, Journal of Inorganic Biochemistry, vol.103, issue.11, pp.1555-62, 2009.
DOI : 10.1016/j.jinorgbio.2009.05.019

M. Rutter, Genetic studies of autism : from the 1970s into the millennium, Journal of Abnormal Child Psychology, vol.28, issue.1, pp.3-14, 2000.
DOI : 10.1023/A:1005113900068

C. Siegrist, Les adjuvants vaccinaux et la myofasciite ?? macrophages, Archives de P??diatrie, vol.12, issue.1, pp.96-101, 2005.
DOI : 10.1016/j.arcped.2004.06.017

F. Ajana, C. Sana, and E. Caulin, Existe-t-il des diff??rences d???immunog??nicit?? et de tol??rance des vaccins en fonction du mode d???injection???, M??decine et Maladies Infectieuses, vol.38, issue.12, pp.648-657, 2008.
DOI : 10.1016/j.medmal.2008.09.012

A. Baumelou, Insuffisance r??nale chronique, EMC - Trait?? de m??decine AKOS, vol.1, issue.1, p.8, 2003.
DOI : 10.1016/S1634-6939(03)36684-0

L. Cunat, Biodisponibilité de I'aluminium dans I'intestin. Etudes in vitro et in vivo chez le rat, Thèse de doctorat spécialité Toxicologie de l'environnement, Metz : UFR Sciences Fondamentales et Appliquées, 1999.

. Société-de-néphrologie-commission-de-dialyse, Information des patients : la dialyse, Néphrologie et Thérapeutiques, issue.2, pp.29-31, 2006.

M. Wills and J. Savory, Water content of aluminum, dialysis dementia, and osteomalacia, Environmental Health Perspectives, vol.63, pp.141-147, 1985.
DOI : 10.1289/ehp.8563141

W. Kaehny, A. Alfrey, R. Holman, and W. Shorr, Aluminum transfer during hemodialysis, Kidney International, vol.12, issue.5, pp.361-365, 1977.
DOI : 10.1038/ki.1977.123

URL : https://doi.org/10.1038/ki.1977.123

I. Parkinson, M. Ward, and D. Kerr, Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis., Journal of Clinical Pathology, vol.34, issue.11, pp.1285-94, 1981.
DOI : 10.1136/jcp.34.11.1285

T. Shirabe, K. Irie, and M. Uchida, Autopsy case of aluminum encephalopathy, Neuropathology, vol.101, issue.3, pp.206-210, 2002.
DOI : 10.1007/s004010050757

A. Alfrey, A. Hegg, and P. Craswell, Metabolism and toxicity of aluminum in renal failure, The American Journal of Clinical Nutrition, vol.33, issue.7, pp.1509-1525, 1980.
DOI : 10.1093/ajcn/33.7.1509

A. English, R. Savage, P. Britton, and M. Ward, Intellectual impairment in chronic renal failure., BMJ, vol.1, issue.6117, pp.888-890, 1978.
DOI : 10.1136/bmj.1.6117.888

H. Elliot, F. Dryburch, G. Fell, and S. Sabet, Aluminium toxicity during regular haemodialysis., BMJ, vol.1, issue.6120, pp.1101-1104, 1978.
DOI : 10.1136/bmj.1.6120.1101

M. Platts, G. Goode, and J. Hislop, Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis., BMJ, vol.2, issue.6088, pp.657-660, 1977.
DOI : 10.1136/bmj.2.6088.657

P. Brunet, V. Faure, S. Burtey, and H. Sichez, An??mie de l'insuffisance r??nale chronique, EMC - N??phrologie, vol.1, issue.1, p.12, 2006.
DOI : 10.1016/S1762-0945(06)40516-7

S. Bhatta, G. Aryal, and R. Kafle, Anemia in chronic kidney disease patients un predialysis and postdialysis stages, J. Pathology Nepal, issue.1, pp.26-29, 2011.

A. Short, R. Winney, and J. Robson, Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication, Proc EDTA, vol.17, pp.226-233, 1980.

T. Druëke, M. Touam, and B. Lacour, Aluminum-induced microcytic anemia in experimental chronic renal failure, Nefrologia, vol.6, issue.3, pp.67-69, 1986.

C. Caramelo, J. Cannata, M. Rodeles, and J. Martin, Mechanisms of aluminum-induced microcytosis: Lessons from accidental aluminum intoxication, Kidney International, vol.47, issue.1, pp.47-164, 1995.
DOI : 10.1038/ki.1995.19

J. Mladenovic, Aluminum inhibits erythropoiesis in vitro., Journal of Clinical Investigation, vol.81, issue.6, pp.1661-65, 1988.
DOI : 10.1172/JCI113502

L. Kaiser, K. Schwartz, M. Burnatowska-hledin, and G. Mayor, Microcytic anemia secondary to intraperitoneal aluminum in normal and uremic rats, Kidney International, vol.26, issue.3, pp.269-274, 1984.
DOI : 10.1038/ki.1984.169

S. Fatemi, F. Kadir, and G. Moore, Aluminium transport in blood serum. Binding of aluminium by human transferrin in the presence of human albumin and citrate, Biochemical Journal, vol.280, issue.2, pp.527-532, 1991.
DOI : 10.1042/bj2800527

A. Mostaghie and A. Skillen, Comparative binding studies of aluminium and iron to serum transferrin, J. Islam. Acad. Sci, issue.3, pp.280-283, 1993.

K. Abreo, J. Glass, and M. Sella, Aluminum inhibits hemoglobin synthesis but enhances iron uptake in friend erythroleukemia cells, Kidney International, vol.37, issue.2, pp.677-681, 1990.
DOI : 10.1038/ki.1990.33

J. Eschbach and J. Adamson, Anemia of end-stage renal disease (ESRD), Kidney International, vol.28, issue.1, pp.1-5, 1985.
DOI : 10.1038/ki.1985.109

M. Yaqoob, R. Ahmad, P. Mcclelland, and K. Shivakumar, Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy., Postgraduate Medical Journal, vol.69, issue.808, pp.69-124, 1993.
DOI : 10.1136/pgmj.69.808.124

R. Oprisiu, C. Hottelart, S. Ghitsu, S. Said, P. Westeel et al., Ostéodystrophie rénale; diagnostic invasif et non invasif des variétés histopathilogiques, Néphrologie, vol.21, issue.5, pp.229-237, 2000.

J. Robertson, A. Felsenfeld, C. Haygood, and P. Wilson, Animal model of aluminum-induced osteomalacia: Role of chronic renal failure, Kidney International, vol.23, issue.2, pp.327-335, 1983.
DOI : 10.1038/ki.1983.23

A. Pierides, W. Edwards, U. Cullum, and J. Mccall, Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness, Kidney International, vol.18, issue.1, pp.115-124, 1980.
DOI : 10.1038/ki.1980.117

M. Platts, G. Owen, and S. Smith, Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water., BMJ, vol.288, issue.6422, pp.969-972, 1984.
DOI : 10.1136/bmj.288.6422.969

G. Cournot-witmer, J. Zingraff, J. Plachot, and F. Escaig, Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization, Kidney International, vol.20, issue.3, pp.375-385, 1981.
DOI : 10.1038/ki.1981.149

A. Sedman, A. Alfrey, N. Miller, and W. Goodman, Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig., Journal of Clinical Investigation, vol.79, issue.1, pp.86-92, 1987.
DOI : 10.1172/JCI112813

L. Quarles, V. Dennis, H. Gitelman, and J. Harrelson, Aluminium deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin Ddeficient dogs, J. Clin. Invest, pp.75-1441, 1985.

D. Andress, H. Nebeker, S. Ott, and D. Endres, Bone histologic response to deferoxamine in aluminium-related bone disease, Kidney Int, vol.13, pp.1344-50, 1987.

A. Felsenfeld, M. Rodriguez, M. Coleman, and D. Ross, Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease, Kidney International, vol.35, issue.6, pp.1371-78, 1989.
DOI : 10.1038/ki.1989.136

M. Ward, T. Feest, H. Ellis, and I. Parkinson, OSTEOMALACIC DIALYSIS OSTEODYSTROPHY: EVIDENCE FOR A WATER-BORNE ??TIOLOGICAL AGENT, PROBABLY ALUMINIUM, The Lancet, vol.311, issue.8069, pp.841-845, 1978.
DOI : 10.1016/S0140-6736(78)90191-5

S. Ahmad, Essentials of water treatment in hemodialysis, Hemodialysis International, vol.9, issue.2, pp.127-134, 2005.
DOI : 10.1097/01.ASN.0000145049.94888.26

F. Décosse, L'aluminium est-il dangereux pour notre santé? Pratiques en nutrition, pp.45-47, 2006.

A. Lione, Aluminum toxicology and the aluminum-containing medications, Pharmacology & Therapeutics, vol.29, issue.2, pp.255-285, 1985.
DOI : 10.1016/0163-7258(85)90032-4

A. Lione, Aluminum intake from non-prescription drugs and sucralfate, General Pharmacology: The Vascular System, vol.16, issue.3, pp.223-228, 1985.
DOI : 10.1016/0306-3623(85)90073-4

S. Kopic and J. Geibel, Gastric Acid, Calcium Absorption, and Their Impact on Bone Health, Physiological Reviews, vol.220, issue.1, pp.189-268, 2013.
DOI : 10.1038/ki.1997.271

P. Jung, Etudes des effets d'une intoxication au chlorure d'aluminium sur la consommation d'oxygène et les capacités d'apprentissage du rat Wistar, Thèse de doctorat spécialité Toxicologie de l'environnement, 1997.

P. Allain, Y. Mauras, N. Kraki, and J. Duchier, Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate [see comments], British Journal of Clinical Pharmacology, vol.302, issue.4, pp.391-395, 1990.
DOI : 10.1002/j.1552-4604.1987.tb02187.x

A. International and L. , The risk of toxic effects with aluminium-containing overthe-counter drugs appears slight in patients with normal renal function, Drugs Ther. Perspect, issue.11, pp.20-39, 2004.

T. Ittel, S. Kinzel, A. Ortmanns, and H. Sieberth, Effect of iron status on the intestinal absorption of aluminum: A reappraisal, Kidney International, vol.50, issue.6, pp.1879-88, 1996.
DOI : 10.1038/ki.1996.509

B. Molitoris, D. Froment, T. Mackenzie, and W. Huffer, Citrate: A major factor in the toxicity of orally administered aluminum compounds, Kidney International, vol.36, issue.6, pp.949-953, 1989.
DOI : 10.1038/ki.1989.286

N. Priest, R. Talbot, J. Austin, and J. Day, The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers, Biometals, issue.9, pp.221-228, 1996.

. Bharathi, P. Vasudevaraju, M. Govindaraju, and A. Palanisamy, Molecular toxicity of aluminium in relation to neurodegeneration, Indian J. Med. Res, vol.128, pp.545-556, 2008.

W. Forbes, J. Gentleman, and C. Maxwell, Concerning the role of aluminum in causing dementia, Experimental Gerontology, vol.30, issue.1, pp.23-32, 1995.
DOI : 10.1016/0531-5565(94)00050-D

J. Walton, Aluminum in hippocampal neurons from humans with Alzheimer's disease, NeuroToxicology, vol.27, issue.3, pp.385-394, 2006.
DOI : 10.1016/j.neuro.2005.11.007

C. Mclachlan, D. Dalton, A. Kruck, T. Bell, and M. , Intramuscular desferrioxamine in patients with Alzheimer's disease, The Lancet, vol.337, issue.8753, pp.1304-1312, 1991.
DOI : 10.1016/0140-6736(91)92978-B

C. Guo, P. Wang, M. Zhong, and T. Wang, Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain, Neurochemistry International, vol.62, issue.2, pp.165-172, 2013.
DOI : 10.1016/j.neuint.2012.12.005

T. Flaten, E. Glattre, A. Viste, and O. Soreide, Mortality from dementia among gastroduodenal ulcer patients., Journal of Epidemiology & Community Health, vol.45, issue.3, pp.203-206, 1991.
DOI : 10.1136/jech.45.3.203

K. Carmichael, M. Fallon, M. Dalinka, and F. Kaplan, Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid, The American Journal of Medicine, vol.76, issue.6, pp.1137-1180, 1964.
DOI : 10.1016/0002-9343(84)90871-4

G. Saadeh, T. Bauer, A. Licata, and L. Sheeler, Antacid-induced osteomalacia, Cleveland Clinic Journal of Medicine, vol.54, issue.3, pp.214-216, 1987.
DOI : 10.3949/ccjm.54.3.214

G. Woodson, An Interesting Case of Osteomalacia Due to Antacid Use Associated With Stainable Bone Aluminum in a Patient With Normal Renal Function, Bone, vol.22, issue.6, pp.695-698, 1998.
DOI : 10.1016/S8756-3282(98)00060-X

G. Beylot, Les soins déodorants et antitranspirants. Actualités pharmaceutiques, pp.51-54, 2011.
DOI : 10.1016/s0515-3700(11)71054-0

M. Martini, D??odorants et antitranspirants, EMC - Cosm??tologie et dermatologie esth??tique, vol.5, issue.1, 2010.
DOI : 10.1016/S1283-0143(10)70754-8

S. Faure, Soins de l'hyperhidrose : antiperspirants et règles hygiéno-diététiques, pp.29-31, 2012.

C. Papa and A. Kligman, Mechanisms of Eccrine Anidrosis. II. The Antiperspirant Effect of Aluminium Salts**Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Journal of Investigative Dermatology, vol.49, issue.2, pp.139-145, 1967.
DOI : 10.1038/jid.1967.115

R. Anane, M. Bonini, J. Grafeille, and E. Creppy, Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice, Archives of Toxicology, vol.1, issue.8, pp.568-571, 1995.
DOI : 10.1073/pnas.87.22.9024

P. Darbre, Aluminium, antiperspirants and breast cancer, Journal of Inorganic Biochemistry, vol.99, issue.9, pp.1912-1931, 2005.
DOI : 10.1016/j.jinorgbio.2005.06.001

M. Namer, E. Luporsi, J. Gligorov, and F. Lokiec, L'utilisation de déodorants/antitranspirants ne constitue pas un risque de cancer du sein, Bull. Cancer, issue.9, pp.95-871, 2008.

E. Collet, G. Jeudy, and S. Dalac, Dermatites de contact aux produits d???hygi??ne, Revue Fran??aise d'Allergologie, vol.49, issue.4, pp.360-365, 2009.
DOI : 10.1016/j.reval.2009.02.015

P. Harvey and P. Darbre, Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?, Journal of Applied Toxicology, vol.24, issue.3, pp.167-176, 2004.
DOI : 10.1002/jat.978

P. Darbre, Underarm cosmetics and breast cancer, Journal of Applied Toxicology, vol.18, issue.20, pp.89-95, 2003.
DOI : 10.2116/analsci.18.761

F. Mannello, G. Tonti, and P. Darbre, Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic breast disease, Journal of Applied Toxicology, vol.88, issue.1, pp.1-6, 2009.
DOI : 10.1007/BF03187140

P. Darbre, D. Pugazhendhi, and F. Mannello, Aluminium and human breast diseases, Journal of Inorganic Biochemistry, vol.105, issue.11, pp.1484-88, 2001.
DOI : 10.1016/j.jinorgbio.2011.07.017

A. Lee, Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses, The Breast, vol.14, issue.2, pp.151-152, 2005.
DOI : 10.1016/j.breast.2004.07.002

P. Darbre, Underarm antiperspirants/deodorants and breast cancer, Breast Cancer Research, vol.23, issue.S3, p.5, 2009.
DOI : 10.1002/jat.886

URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2424?site=breast-cancer-research.biomedcentral.com

P. Darbre and A. Charles, Environmental oestrogens and breast cancer : evidence for combined involvement of dietary, household and cosmetic xenoestrogens, Anticancer Res, vol.30, pp.815-828, 2010.

P. Darbre, Recorded quadrant incidence of female breast cancer in Great Britain suggests a disproportionate increase in the upper outer quadrant of the breast

C. Exley, L. Charles, L. Barr, and C. Martin, Aluminium in human breast tissue, Journal of Inorganic Biochemistry, vol.101, issue.9, pp.1344-1390, 2007.
DOI : 10.1016/j.jinorgbio.2007.06.005

E. Routledge, J. Parker, J. Odum, and J. Ashby, Some Alkyl Hydroxy Benzoate Preservatives (Parabens) Are Estrogenic, Toxicology and Applied Pharmacology, vol.153, issue.1, pp.12-19, 1998.
DOI : 10.1006/taap.1998.8544

M. Bilimoria, D. Winchester, S. Sener, and G. Motykie, Estrogen Replacement Therapy and Breast Cancer: Analysis of Age of Onset and Tumor Characteristics, Annals of Surgical Oncology, vol.277, issue.2, pp.200-207, 1999.
DOI : 10.1007/s10434-999-0200-7

T. Busk and J. Clemmesen, The Frequencies of Left- and Right-sided Breast Cancer, British Journal of Cancer, vol.1, issue.4, pp.345-351, 1947.
DOI : 10.1038/bjc.1947.31

D. Mirick, S. Davis, and D. Thomas, Antiperspirant Use and the Risk of Breast Cancer, CancerSpectrum Knowledge Environment, vol.94, issue.20, pp.94-1578, 2002.
DOI : 10.1093/jnci/94.20.1578

P. Darbre, A. Bakir, and E. Iskakova, Effect of aluminium on migratory and invasive properties of MCF-7 human breast cancer cells in culture, Journal of Inorganic Biochemistry, vol.128, p.5, 2013.
DOI : 10.1016/j.jinorgbio.2013.07.004

D. Lambert, Traitement de l'hyperhidrose en dehors des antisudoraux, EMC, p.4, 2000.

I. Hosten, Hyperhidroses : du symptôme au diagnostic, EMC, vol.7, issue.3, pp.1-6, 2012.

A. Pons-guiraud, Intolérance aux cosmétiques, Actualisation. EMC, p.10, 2007.